Walter Roger - Adocia Head of Industrial Property Department
| ADOC Stock | EUR 8.75 0.13 1.51% |
Executive
Mr. Walter Roger is Head of Industrial Property Department at Adocia SAS. He holds a doctorate in organic chemistry. He is also a professional representative accredited by the European Patent Office . Walter began his career with the Regimbeau firm, and then worked for various industrial property firms. At his last position with Rhodia, he consolidated his experience in drafting patent applications, overseeing the examination procedure, providing rightofuse opinions, and studying patentability.
| Phone | (33) 04 72 36 39 67 |
| Web | www.adocia.com |
Adocia Management Efficiency
The company has return on total asset (ROA) of (0.245) % which means that it has lost $0.245 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (3.6138) %, meaning that it generated substantial loss on money invested by shareholders. Adocia's management efficiency ratios could be used to measure how well Adocia manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 14 records | EXECUTIVE Age | ||
| Philippe Pouletty | Innate Pharma | 55 | |
| JeanYves Blay | Innate Pharma | 55 | |
| Karsten Knudsen | Innate Pharma | 44 | |
| Eric Vivier | Innate Pharma | N/A | |
| Stephan Reynier | Cellectis | N/A | |
| Pierre Dodion | Innate Pharma | 61 | |
| Marcus Schindler | Innate Pharma | 51 | |
| Mailys Ferrere | Innate Pharma | 55 | |
| Patrick Langlois | Innate Pharma | 70 | |
| Veronique Chabernaud | Innate Pharma | 56 | |
| Philippe Duchateau | Cellectis | 60 | |
| Michael Caligiuri | Innate Pharma | 57 | |
| JeanCharles Soria | Innate Pharma | N/A | |
| MarieBleuenn Terrier | Cellectis | 41 | |
Management Performance
| Return On Equity | -3.61 | |||
| Return On Asset | -0.24 |
Adocia Leadership Team
Elected by the shareholders, the Adocia's board of directors comprises two types of representatives: Adocia inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Adocia. The board's role is to monitor Adocia's management team and ensure that shareholders' interests are well served. Adocia's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Adocia's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jose Correia, Head of the Preclinical and Clinical Department, HSQE Manager and Project Manager | ||
| Valerie Danaguezian, Chief Financial Officer, Administrative Director | ||
| Ekaterina Smirnyagina, Independent Director | ||
| Laurent Arthaud, Director Representative of Bpifrance Investissement | ||
| Remi Soula, Co-Founder, Director of Bus. Devel. and Intellectual Property and Scientific Advisor | ||
| Valrie Danaguezian, CFO Director | ||
| Grard Soula, Chairman, CoFounder | ||
| Geraldine Soula, Director of Development and Human Resources | ||
| Olivier MBA, Deputy CoFounder | ||
| Emmanuel Dauty, Head of Physical Chemistry | ||
| Olivier Martinez, Member of the Board | ||
| Gerard Soula, Chairman of the Board, Chief Executive Officer | ||
| Bertrand Alluis, Head of Analysis Department and Project Manager | ||
| Joachim Garric, Head of Analysis Department | ||
| Walter Roger, Head of Industrial Property Department | ||
| Dominique Takizawa, Independent Member of the Board | ||
| Martin Gaudier, Head of Biology Department | ||
| Olivier Soula, Deputy Chief Executive Officer, Vice President - Research & Development, Director | ||
| David Duracher, Head of Pharmaceutical Development and Physical Chemistry Departments | ||
| Frederic Leroy, Head of Chemistry Department | ||
| Gregory Meiffren, Head of Biology Department | ||
| YouPing Chan, Scientific Director | ||
| Stanislav Glezer, Medical Doctor | ||
| Grgory Meiffren, Head Mang | ||
| Sarah Gould, Director of the Preclinical Department | ||
| Richard Charvet, Head of Chemistry Department |
Adocia Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Adocia a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -3.61 | |||
| Return On Asset | -0.24 | |||
| Profit Margin | (0.57) % | |||
| Operating Margin | (1.06) % | |||
| Current Valuation | 33.73 M | |||
| Shares Outstanding | 8.9 M | |||
| Shares Owned By Insiders | 21.71 % | |||
| Shares Owned By Institutions | 16.00 % | |||
| Price To Earning | 18.12 X | |||
| Price To Book | 10.54 X |
Pair Trading with Adocia
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adocia position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adocia will appreciate offsetting losses from the drop in the long position's value.Moving together with Adocia Stock
| 0.77 | ALTHE | Theradiag SA Earnings Call Tomorrow | PairCorr |
| 0.75 | GNFT | Genfit | PairCorr |
| 0.81 | ALEUP | Europlasma SA Earnings Call Today | PairCorr |
The ability to find closely correlated positions to Adocia could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adocia when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adocia - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adocia to buy it.
The correlation of Adocia is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adocia moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adocia moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Adocia can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adocia. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for Adocia Stock analysis
When running Adocia's price analysis, check to measure Adocia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adocia is operating at the current time. Most of Adocia's value examination focuses on studying past and present price action to predict the probability of Adocia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adocia's price. Additionally, you may evaluate how the addition of Adocia to your portfolios can decrease your overall portfolio volatility.
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |